Biotechnology News

November 15, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent (LOI) with Geron...

November 15, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stent portfolio, company officials reported today. It’s the...

November 15, 2012

CHICAGO--(BUSINESS WIRE)--Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced that the European Medicines Agency (EMA) has designated Naloxone hydrochloride dehydrate as...

November 15, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Rick Morrison of Comprehend Systems will join health IT experts from leading companies in a one-day health information technology conference sponsored by the Life Science Angel Network (LSAN).

November 15, 2012

PHILADELPHIA & EMERYVILLE, Calif.--(BUSINESS WIRE)--Integral Molecular and Crystal Bioscience Announce Research Collaboration to Develop Novel GPCR and Ion Channel Antibodies

November 15, 2012

WELLESLEY HILLS, Mass.--(BUSINESS WIRE)--BioBridges, LLC, a clinical development consultancy serving the biopharmaceutical community, announced today the appointment of David P. Lucey as Director of ClinPath. Mr. Lucey will develop and market...

November 15, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Cmed Inc. today announced the relocation of its North Carolina office to new, larger premises in Creekstone Park, Durham, N.C..

November 15, 2012

CARY, N.C.--(BUSINESS WIRE)--ISR's report provides insight into the adaptive clinical trial market including industry-wide adoption levels, outsourcing, study types, and future market trends.

November 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Exploring mobile strategies’ total value opportunity requires companies to engage in active conversations with target audiences, finds Cutting Edge Information.

November 15, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite a decline in sales owing to the generic entry of most triptans, the...

November 15, 2012

SEATTLE--(BUSINESS WIRE)--Natural Molecular Testing names Manju T. Beier, Pharm D., as CSO; genetic testing provides physicians with guidance in prescribing and dosing medications for patients

November 15, 2012

LAVAL, Quebec--(BUSINESS WIRE)--INCIVEK™ (telaprevir) Now Funded in Alberta and New Brunswick for People with Hepatitis C

November 15, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) reported unaudited financial results for the nine months ended September 30, 2012. As previously reported, the Company continues to seek financing or a strategic partner. The...

November 15, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that, although Vertex’s Incivek (telaprevir) and Merck’s Victrelis (boceprevir) have...

November 15, 2012

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook’s peripheral intervention and diagnostic devices will be offered to the more than 65,000 health care members served by Novation.

November 15, 2012

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics ™, today announced that Stephen A. Hill, M.D. has been appointed as President and Chief Executive...

November 15, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced the presentation today of favorable results from a Phase 1b/2 clinical trial with its tumor-...

November 15, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2012 fiscal year (FY12) and fourth quarter (4Q12)...

November 15, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Tikcro Technologies Ltd. (OTC PK: TIKRF) today reported results for the third quarter ended September 30, 2012. Net loss for the third quarter was $444,000, or $0.05 per diluted share. Results for the third...

November 15, 2012

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--CardioNet, Inc. (NASDAQ:BEAT), the leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced the launch of its new wireless event...

November 15, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (NASDAQ: INCY) announced today that it has earned a $50 million milestone payment from Eli Lilly and Company based on the formal initiation of the rheumatoid arthritis (RA) Phase III program...

November 15, 2012

TORONTO--(BUSINESS WIRE)--The most significant growth in clot management in Brazil, Russia, India and China will be in percutaneous thrombectomy devices and neurovascular embolectomy devices.

November 15, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC JV Target Amarantus Secures $1.1 Million in Financing

November 15, 2012

DUBAI & WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences Inc. announced today they have signed an exclusive strategic distribution agreement with the Alliance Global Group (AGBL) to help clinicians in emerging markets diagnose and...

November 15, 2012

ZUG, Switzerland--(BUSINESS WIRE)--Foster Wheeler AG (Nasdaq: FWLT) announced today that a joint venture of a subsidiary of its Global Engineering and Construction Group (Foster Wheeler Canada Ltd.) and Three Streams Engineering Ltd. has been...

November 15, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced it has completed patient enrollment in its DeeP-C pivotal trial for colorectal cancer screening. The study enrolled more than 12,700 patients.

November 15, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

November 15, 2012

GLASGOW, England--(BUSINESS WIRE)--Gilead Sciences (Nasdaq:GILD) today announced two-year (96-week) results from two pivotal Phase 3 studies (Studies 102 and 103) evaluating the company’s newest single tablet HIV regimen, StribildTM (elvitegravir...

November 15, 2012

TOKYO--(BUSINESS WIRE)--Hitachi Chemical Co., Ltd., in the field of life sciences, developed a novel mRNA quantitative assay called "Hem(A)+ System".

November 15, 2012

GLASGOW, England--(BUSINESS WIRE)--Gilead Sciences (Nasdaq:GILD) today announced Phase 3b clinical trial results from STaR (Single Tablet Regimen), the first head-to-head study comparing the single tablet regimens Complera® (emtricitabine/...

November 15, 2012

GARDEN CITY, N.Y.--(BUSINESS WIRE)--ImaCor Inc., the developer of the world’s only hemodynamic transesophageal echocardiography (hTEE™) management device, announced that the first in a planned series of symposia presenting hTEE study findings and...

November 15, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--University College London Cancer Institute Selects RainDance’s ThunderStorm™ System for High-Throughput Targeted Sequencing

November 15, 2012

CHALFONT ST. GILES, England--(BUSINESS WIRE)--Dr. Michelle Janas from GE Healthcare Life Sciences recently swapped a lab coat for legislation, when she visited Jenny Willott MP at the House of Commons for a “Week in Westminster” as part of a...

November 15, 2012

SAN JOSE, Calif.--(BUSINESS WIRE)--NDS Surgical Imaging wins Best of Show at 2012 Excellence in Surgical Products Awards

November 14, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences reports financial results for the third quarter 2012

November 14, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, held the second and...

November 14, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro”) announced today that it has postponed its extraordinary general meeting of shareholders and the class meeting of holders of ordinary shares, originally...

November 14, 2012

REYKJAVIK, Iceland--(BUSINESS WIRE)--deCODE Genetics reported today in the New England Journal of Medicine the identification of just the second gene variant found to confer high risk of acquiring Alzheimer’s disease.

November 14, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that its Semprus BioSciences subsidiary has been granted 510(k) clearance for the Company’...

November 14, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics Reports Third Quarter 2012 Financial Results

November 14, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) will present at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, Nov. 27, in New York City. John Heinmiller, executive vice president, and Don Zurbay, chief...

November 14, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, reported its financial results for the quarter and nine months ended September 30, 2012. Kevin D. Clark, Chief Executive Officer,...

November 14, 2012

DENVER & ATLANTA--(BUSINESS WIRE)--The Global Down Syndrome Foundation and the National Down Syndrome Congress announced the English and Spanish publication of the first Down Syndrome Prenatal Testing Pamphlet.

November 14, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced it ranked 185 on Deloitte’s Technology Fast 500™ list, which ranks the 500 fastest growing technology, media, telecommunications, life sciences companies.

November 14, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today publishes the major key...

November 14, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid antisense cancer drugs, today announced that it has completed treatment of the...

November 14, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities.

November 14, 2012

PARIS & LONDON--(BUSINESS WIRE)--Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes